Real-World study tests daily pill for diabetes control
NCT ID NCT05316662
First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 30 times
Summary
This completed study in Mexico followed 187 adults with type 2 diabetes who were already prescribed oral semaglutide (Rybelsus) by their doctor. The goal was to see how well the once-daily pill lowers blood sugar and affects body weight over 8-10 months. Participants also filled out questionnaires about their treatment. The study is observational, meaning it simply collected data from routine care without changing how patients were treated.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CICEJ Centro de Investigacion Clinica Endocrinologica de Jalisco SC
Guadalajara, Jalisco, 44670, Mexico
-
Centro de Investigacion Clinica Endocrinologica de Jalisco
Guadalajara, Jalisco, 44670, Mexico
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
semaglutide (Rybelsus)
What this could lead to
If results are positive, this could confirm that oral semaglutide helps control blood sugar and weight in real-world settings, supporting its use for type 2 diabetes.
What could go wrong
This is an observational study without a comparison group, so results may be influenced by other factors. It also only includes Mexican adults, so findings may not apply to everyone.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.